Stanford Program to Accelerate Robotic Children's Surgery
NCT06671639
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide an initial assessment to evaluate the feasibility, safety, and effectiveness for the utilization of the da Vinci Xi on pediatric and adolescent patients. This clinical trial will be conducted under the auspices of Stanford University's IRB approval.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Sleeve Gastrectomy
- Cholecystectomy
- Splenectomy
- Hysterectomy
- Endometriosis
- Ureteral Re-implant
- Cervical and Thoracic Tracheoplasty
- Thymectomy
- Lobectomy/Wedge Lung Resection
- Lung Segmentectomy
- Bronchoplasty
- Endoscopic Laryngeal/Pharyngeal Suturing
- Vocal Feminization
- Laryngeal Cleft Repair
- Endolaryngeal Adjacent Tissue Transfer
- Pharyngoplasty
- Ileocolonic Resections
- Laryngoplasty
- Proctectomy With Ileal Pouch-Anal Anastomosis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 6 to 21 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Stanford University
- Last updated on ClinicalTrials.gov
- April 30, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Lucile Packard Children's Hospital Stanford · Stanford, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.